abstract |
The present invention discloses isolated monoclonal antibodies and related antibody-based compositions and molecules that bind to human c-Met, the hepatocyte growth factor receptor. Also disclosed are pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods using the antibodies. |